Roundtable Discussion: Addressing Management of Patients with Metastatic CRPC Following Frontline Treatments
During a Targeted Oncology Case-Based Roundtable event, David I. Quinn, MD, PhD, MBBS leads a discussion on treatment for metastatic castration-resistant prostate cancer following frontline treatment.